These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7767638)

  • 1. Retroviruses as vectors.
    Vile RG; Russell SJ
    Br Med Bull; 1995 Jan; 51(1):12-30. PubMed ID: 7767638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of gene therapy for blood disorders: an update.
    Nienhuis AW
    Blood; 2013 Aug; 122(9):1556-64. PubMed ID: 23843498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between Retroviruses and the Host Cell Genome.
    Poletti V; Mavilio F
    Mol Ther Methods Clin Dev; 2018 Mar; 8():31-41. PubMed ID: 29159201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-based non-viral gene delivery: A comprehensive review of the advances and challenges.
    Xiang K; Li Y; Cong H; Yu B; Shen Y
    Int J Biol Macromol; 2024 May; 266(Pt 1):131194. PubMed ID: 38554914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroviral gene therapy in Germany with a view on previous experience and future perspectives.
    Morgan MA; Galla M; Grez M; Fehse B; Schambach A
    Gene Ther; 2021 Sep; 28(9):494-512. PubMed ID: 33753908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vector production in an academic environment: a tool to assess production costs.
    Boeke A; Doumas P; Reeves L; McClurg K; Bischof D; Sego L; Auberry A; Tatikonda M; Cornetta K
    Hum Gene Ther Methods; 2013 Feb; 24(1):49-57. PubMed ID: 23360377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gene therapy for treatment of acute inflammatory immune response].
    Tschöke SK; Oberholzer A
    Orthopade; 2007 Mar; 36(3):259-64. PubMed ID: 17333067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technological advancements in viral vector designing and optimization for therapeutic applications.
    Singh S; Pandey AK; Malemnganba T; Prajapati VK
    Adv Protein Chem Struct Biol; 2024; 139():57-87. PubMed ID: 38448144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering siRNA therapeutics: challenges and strategies.
    Ali Zaidi SS; Fatima F; Ali Zaidi SA; Zhou D; Deng W; Liu S
    J Nanobiotechnology; 2023 Oct; 21(1):381. PubMed ID: 37848888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges.
    Ghosh S; Brown AM; Jenkins C; Campbell K
    Appl Biosaf; 2020 Mar; 25(1):7-18. PubMed ID: 36033383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Cellular Micropharmacies: Cells Engineered for Localized Drug Delivery.
    Gardner TJ; Bourne CM; Dacek MM; Kurtz K; Malviya M; Peraro L; Silberman PC; Vogt KC; Unti MJ; Brentjens R; Scheinberg D
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32764348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia.
    Vairy S; Garcia JL; Teira P; Bittencourt H
    Drug Des Devel Ther; 2018; 12():3885-3898. PubMed ID: 30518999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pantropic retroviruses as a transduction tool for sea urchin embryos.
    Core AB; Reyna AE; Conaway EA; Bradham CA
    Proc Natl Acad Sci U S A; 2012 Apr; 109(14):5334-9. PubMed ID: 22431628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foamy virus: an available vector for gene transfer in neural cells and other nondividing cells.
    Zhang Y; Liu Y; Zhu G; Qiu Y; Peng B; Yin J; Liu W; He X
    J Neurovirol; 2010 Nov; 16(6):419-26. PubMed ID: 20969536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral vectors for vascular gene therapy.
    Fischer L; Preis M; Weisz A; Koren B; Lewis BS; Flugelman MY
    Exp Clin Cardiol; 2002; 7(2-3):106-12. PubMed ID: 19649233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of retroviruses for the overexpression of cytosolic and mitochondrial glutathione reductase in macrophages in vivo.
    Kisgati M; Asmis R
    Cytotechnology; 2007 May; 54(1):5-14. PubMed ID: 19003013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-apoptotic therapy with a Tat fusion protein protects against excitotoxic insults in vitro and in vivo.
    Ju KL; Manley NC; Sapolsky RM
    Exp Neurol; 2008 Apr; 210(2):602-7. PubMed ID: 18207142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy trials for the treatment of high-grade gliomas.
    Sonabend AM; Ulasov IV; Lesniak MS
    Gene Ther Mol Biol; 2007; 11(A):79-92. PubMed ID: 17625614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery systems for pulmonary gene therapy.
    Gautam A; Waldrep CJ; Densmore CL
    Am J Respir Med; 2002; 1(1):35-46. PubMed ID: 14720074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector.
    Kubo S; Mitani K
    J Virol; 2003 Mar; 77(5):2964-71. PubMed ID: 12584321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.